Nutritional Deficiencies, Complications, and Nutrition Therapy/Counseling in Pediatric Patients Using GLP-1 Receptor Agonists
A claims-based study reported nutritional deficiency diagnoses among pediatric GLP-1 receptor agonist users.
TL;DR
- The study identified 2,031 GLP-1 receptor agonist users aged 10–17 in U.S. claims data from 2017–2022.
- Within one year, 16.88% had a nutritional deficiency or related complication recorded; vitamin D deficiency was most common.
- The claims result is observational; separately, Nature reports continuing research into why GLP-1 drugs do not help some people lose weight.
The PubMed-indexed study examined 2,031 continuously enrolled patients aged 10–17 who used GLP-1 receptor agonists and had no prior nutritional-deficiency diagnosis. [1]
The paper reports that 16.88% received a diagnosis of a nutritional deficiency or related complication within one year; vitamin D deficiency was the most common. ScienceDaily summarized the same study. [1] [2]
The authors used administrative claims data, so these results describe recorded diagnoses in the studied population and do not establish that treatment caused them. [1]
Separately, Nature reports that researchers are investigating why some people taking GLP-1 drugs do not lose weight; this broader efficacy question is distinct from the pediatric claims analysis summarized above. [3]
Why it matters
The finding concerns monitoring and study design in pediatric treatment research; it does not support individual treatment advice.
Editor's note
The headline is the primary paper title. The reported percentages come from the article abstract; claims data cannot establish causation.